Stock 1786 SCIVISION BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials SciVision Biotech Inc.

Equities

1786

TW0001786002

Medical Equipment, Supplies & Distribution

End-of-day quote Taiwan S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
107 TWD +0.94% Intraday chart for SciVision Biotech Inc. -0.93% +37.89%
04-10 SciVision Biotech Inc.?s Products, Flexotron Solo (2.2%) and Flexotron Magnum (3%) Obtain Medical Device Licenses CI
04-09 Scivision Biotech Inc.'s CREATEFILL Obtains Medical Device License of Class III Medical Devices CI

Valuation

Fiscal Period: December 2019 2024 2025
Capitalization 1 4,172 7,247 -
Enterprise Value (EV) 1 4,172 7,247 7,247
P/E ratio - - -
Yield - - -
Capitalization / Revenue 9.53 x 7 x 4.93 x
EV / Revenue 9.53 x 7 x 4.93 x
EV / EBITDA 25.9 x 18.1 x 12.6 x
EV / FCF - - -
FCF Yield - - -
Price to Book - - -
Nbr of stocks (in thousands) 66,190 67,731 -
Reference price 2 63.02 107.0 107.0
Announcement Date 20-03-23 - -
1TWD in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2024 2025
Net sales 1 437.9 1,036 1,469
EBITDA 1 160.8 401 577
EBIT 1 134.2 339 517
Operating Margin 30.65% 32.72% 35.19%
Earnings before Tax (EBT) - - -
Net income - - -
Net margin - - -
EPS - - -
Free Cash Flow - - -
FCF margin - - -
FCF Conversion (EBITDA) - - -
FCF Conversion (Net income) - - -
Dividend per Share - - -
Announcement Date 20-03-23 - -
1TWD in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 195 220 280 342 294
EBITDA - - - - -
EBIT 1 50 63 95 131 87
Operating Margin 25.64% 28.64% 33.93% 38.3% 29.59%
Earnings before Tax (EBT) - - - - -
Net income - - - - -
Net margin - - - - -
EPS - - - - -
Dividend per Share - - - - -
Announcement Date - - - - -
1TWD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2024 2025
Net Debt - - -
Net Cash position - - -
Leverage (Debt/EBITDA) - - -
Free Cash Flow - - -
ROE (net income / shareholders' equity) 9.9% 17.2% 23.7%
ROA (Net income/ Total Assets) 6.79% 13.1% 18.1%
Assets - - -
Book Value Per Share - - -
Cash Flow per Share - - -
Capex 1 201 10 8
Capex / Sales 45.87% 0.97% 0.54%
Announcement Date 20-03-23 - -
1TWD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
107 TWD
Average target price
131 TWD
Spread / Average Target
+22.43%
Consensus

Quarterly revenue - Rate of surprise

Company calendar

Sector Medical Devices & Implants

1st Jan change Capi.
SCIVISION BIOTECH INC. Stock SciVision Biotech Inc.
+37.89% 224M
STRYKER CORPORATION Stock Stryker Corporation
+9.68% 125B
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-7.58% 10.91B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
+2.17% 8.93B
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
+22.75% 7.57B
GLAUKOS CORPORATION Stock Glaukos Corporation
+33.99% 5.36B
AXONICS, INC. Stock Axonics, Inc.
+8.12% 3.43B
ENOVIS CORPORATION Stock Enovis Corporation
-8.48% 2.81B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-5.07% 2.23B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-4.22% 2.13B
Medical Devices & Implants
  1. Stock Market
  2. Equities
  3. 1786 Stock
  4. Financials SciVision Biotech Inc.